Envoy Medical (COCH) Stock Price, News & Analysis

Company Overview

Envoy Medical, Inc. is a medical device company focused on developing fully implanted hearing solutions for people with hearing loss. The company’s technology is designed to use the body’s natural anatomy to capture sound and deliver hearing signals without the need for externally worn components.

Its lead product is the Acclaim Fully Implanted Cochlear Implant, an investigational device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation. Unlike conventional cochlear implants, the Acclaim system is designed to be fully implanted, including its sound-sensing component, with the goal of allowing users to hear without an external sound processor. The device has received the U.S. Food and Drug Administration’s Breakthrough Device designation and has been under clinical development.

Envoy Medical is headquartered in White Bear Lake, Minnesota, and serves the hearing-implant market primarily through research, product development and clinical activities. The company was founded in 1995 and is led by Chief Executive Officer Brent Lucas.

Key Stats

• Today's Range: $0.66 to $0.67
• 50-Day Range: $0.64 to $0.80
• 52-Week Range: $0.36 to $1.89
• Volume: 29,085 shs
• Average Volume: 409,283 shs
• Market Capitalization: $50.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $2.17
• Consensus Rating: Hold

Envoy Medical Stock Analysis - MarketRank™

Envoy Medical scored higher than 61% of companies evaluated by MarketBeat, and ranked 485th out of 885 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Envoy Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Envoy Medical has a consensus price target of $2.17, representing about 225.8% upside from its current price of $0.67.

Amount of Analyst Coverage

Envoy Medical has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Envoy Medical are expected to grow in the coming year, from ($0.31) to ($0.18) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Envoy Medical is -0.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envoy Medical is -0.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.74% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 10.79, which indicates bearish sentiment.

Change versus previous month

Short interest in Envoy Medical has recently decreased by 12.66%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envoy Medical does not currently pay a dividend.

Dividend Growth

Envoy Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 3.6 / 5
• News Sentiment: 0.75

News Sentiment

Envoy Medical has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Envoy Medical this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Envoy Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

7.20% of the stock of Envoy Medical is held by insiders.

Percentage Held by Institutions

8.59% of the stock of Envoy Medical is held by institutions.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 10/06/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:COCH
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: (651) 361-8000
• Fax: N/A
• Employees: 47
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Envoy Medical: $2.17
• High Price Target: $2.50
• Low Price Target: $2.00
• Potential Upside/Downside: +225.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.76)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.76 million
• Net Margins: -11,304.83%
• Pretax Margin: -11,304.83%
• Return on Equity: N/A
• Return on Assets: -144.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.73
• Quick Ratio: 1.61

Sales & Book Value

• Annual Sales: $207 thousand
• Price / Sales: 247.99
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.42) per share
• Price / Book: -1.58

Miscellaneous

• Outstanding Shares: 77,195,000
• Free Float: 71,637,000
• Market Cap: $51.33 million
• Optionable: Not Optionable
• Beta: 1.97